IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Kalehua Capital Management LLC

Q2 2026 Holdings

Filed 2026-08-14 | 26 holdings | $174.0M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2026-08-19) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
EA Series Trust(BOXX)AALPHA ARCH 1-302072L565$26.5M226,18815.2%
Veradermics Inc(MANE)COMMON STOCK922967104$17.9M145,69510.3%
X4 Pharmaceuticals Inc(XFOR)COM NEW98420X202$17.4M3,722,84010.0%
Compass Pathways Plc(CMPS)SPONSORED ADS20451W101$11.6M819,6926.7%
Surrozen Inc(SRZN)COM NEW86889P208$10.0M385,1785.7%
Aclaris Therapeutics Inc(ACRS)COM00461U105$9.7M1,832,3655.6%
Sionna Therapeutics Inc(SION)COM829401108$8.7M197,0725.0%
Inhibikase Therapeutics Inc(IKT)COM NEW45719W205$7.8M3,821,8904.5%
Pharvaris NV(PHVS)COMN69605108$6.9M198,7724.0%
Karyopharm Therapeutics Inc(KPTI)COM NEW48576U205$6.7M685,6443.9%
Septerna Inc(SEPN)COM81734D104$6.5M194,5443.7%
Inflarx Nv(IFRX)COMN44821101$6.5M2,897,7693.7%
Cyclerion Therapeutics Inc(CYCN)COM23255M204$5.6M1,651,3503.2%
Korro Bio Inc(KRRO)ACOM500946108$5.3M405,0403.1%
Uniqure Nv(QURE)SHSN90064101$3.7M79,4072.1%
LeonaBio Inc(LONA)COM04746L203$3.6M393,7012.1%
Damora Therapeutics Inc(GLTO)COM NEW36322Q206$3.6M139,0002.1%
MoonLake Immunotherapeutics(MLTX)CLASS A ORD61559X104$3.4M175,7342.0%
Adlai Nortye(ANL)ASPONSORED ADS00704R109$2.6M226,4151.5%
Tyra Biosciences Inc(TYRA)COM90240B106$2.4M74,4651.4%
Nuvectis Pharma Inc(NVCT)COM67080T108$1.8M100,0001.1%
Gossamer Bio Inc(GOSS)COM38341P102$1.8M11,149,3631.1%
Milestone Pharmaceuticals Inc(MIST)COM59935V107$1.7M1,269,2371.0%
Atyr Pharma Inc(ATYR)COM NEW002120202$1.1M1,788,1670.6%
Instil Bio Inc(TIL)COM NEW45783C200$765.9K99,6000.4%
Tscan Therapeutics Inc(TCRX)COM89854M101$445.8K454,8760.3%